Impact of Baseline Smoking Status and Body Mass Index in Patients with Hidradenitis Suppurativa Treated with Adalimumab or Placebo in Phase 2 or 3 Studies

Main Article Content

Amit Garg
Hessel H van der Zee
Ziqian Geng
Gerit D Mulder


adalimumab, hidradenitis suppurativa, smoking, body mass index


Abstract Not Available


Disclosures: Study supported by AbbVie.